PT75217B - Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung - Google Patents

Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung

Info

Publication number
PT75217B
PT75217B PT75217A PT7521782A PT75217B PT 75217 B PT75217 B PT 75217B PT 75217 A PT75217 A PT 75217A PT 7521782 A PT7521782 A PT 7521782A PT 75217 B PT75217 B PT 75217B
Authority
PT
Portugal
Prior art keywords
preparation
authoritative
xanthine derivatives
medicinal preparations
gastric juice
Prior art date
Application number
PT75217A
Other languages
German (de)
English (en)
Other versions
PT75217A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6136567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT75217(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT75217A publication Critical patent/PT75217A/pt
Publication of PT75217B publication Critical patent/PT75217B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
PT75217A 1981-07-10 1982-07-08 Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung PT75217B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813127237 DE3127237A1 (de) 1981-07-10 1981-07-10 Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PT75217A PT75217A (de) 1982-08-01
PT75217B true PT75217B (de) 1985-01-07

Family

ID=6136567

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75217A PT75217B (de) 1981-07-10 1982-07-08 Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung

Country Status (17)

Country Link
US (1) US4542011A (pt)
EP (1) EP0069958B2 (pt)
JP (1) JPS5818318A (pt)
KR (1) KR880000971B1 (pt)
AT (1) ATE18851T1 (pt)
AU (1) AU553925B2 (pt)
CA (1) CA1178204A (pt)
DD (1) DD202502A5 (pt)
DE (2) DE3127237A1 (pt)
DK (1) DK166758B1 (pt)
FI (1) FI81259C (pt)
HU (1) HU187774B (pt)
IE (1) IE53581B1 (pt)
IL (1) IL66282A (pt)
NO (1) NO157244C (pt)
PT (1) PT75217B (pt)
ZA (1) ZA824901B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4874605A (en) * 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
IN186245B (pt) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064230A (en) * 1966-04-25 1977-12-20 Schmid Laboratories, Inc. Polyenic macrolide compositions
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
BE725125A (pt) * 1967-12-16 1969-06-09
IL45337A (en) * 1973-08-10 1977-04-29 Saarstickstoff Fatol Gmbh Therapeutical composition containing an isonicotinic acid hydrazide thioisonicotinic acid amide sulfones and/or sulfonamides for the treatment of mycobacterioses
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
AR215459A1 (es) * 1976-04-02 1979-10-15 Brewer J Metodo para producir un agente terapeutico capaz de proporcionar una marca en un animal no humano para indicar la administracion del agente al animal y para proporcionar tambien un repositorio del agente a ser libeberado durante un espacio de tiempo
US4096252A (en) * 1976-06-10 1978-06-20 J. Uriach & Cia S.A. 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
JPS5611687A (en) * 1980-06-02 1981-02-05 Fujitsu Ltd Semiconductor memory unit

Also Published As

Publication number Publication date
IL66282A (en) 1987-01-30
FI822441A0 (fi) 1982-07-08
US4542011A (en) 1985-09-17
DE3270241D1 (en) 1986-05-07
PT75217A (de) 1982-08-01
DK166758B1 (da) 1993-07-12
JPH0419969B2 (pt) 1992-03-31
FI822441L (fi) 1983-01-11
HU187774B (en) 1986-02-28
IE821661L (en) 1983-01-10
JPS5818318A (ja) 1983-02-02
EP0069958A2 (de) 1983-01-19
IE53581B1 (en) 1988-12-21
AU553925B2 (en) 1986-07-31
ZA824901B (en) 1983-04-27
ATE18851T1 (de) 1986-04-15
DD202502A5 (de) 1983-09-21
EP0069958B1 (de) 1986-04-02
NO157244B (no) 1987-11-09
NO822399L (no) 1983-01-11
FI81259C (fi) 1990-10-10
NO157244C (no) 1988-02-24
EP0069958B2 (de) 1991-03-27
AU8578082A (en) 1983-01-13
KR840000238A (ko) 1984-02-18
EP0069958A3 (en) 1983-06-29
IL66282A0 (en) 1982-11-30
KR880000971B1 (ko) 1988-06-07
DE3127237A1 (de) 1983-01-20
FI81259B (fi) 1990-06-29
DK310582A (da) 1983-01-11
CA1178204A (en) 1984-11-20

Similar Documents

Publication Publication Date Title
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
IL58849A0 (en) Amino acid derivatives their preparation and pharmaceutical compositions containing them
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
IL56734A0 (en) Phemoxyalkylcarboxylic acid derivatives,process for their preparation and pharmaceutical compositions containing thesame
PT86236A (en) Process for the preparation of catechol derivatives and of pharmaceutical compositions containing them
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
IL61307A (en) Derivatives of 6beta-hydroxyalkylpenicillanic acids,their preparation and pharmaceutical compositions containing them
PT75217A (de) Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
DE19975037I2 (de) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-on-Derivate Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2966142D1 (en) Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
PT69821A (en) Process for the preparation of new 5-phenylpyrazole derivatives the salts thereof and the pharmaceutical compositions containing same
DE2961571D1 (en) Penicillins, their salts, process for their preparation and pharmaceutical compositions containing them
IL72471A0 (en) Pharmaceutical compositions containing phenylquinoline-carboxylic acids and derivatives thereof,certain such novel compounds and their preparation
EP0003833A3 (en) Antigen derivatives, process for their preparation, pharmaceutical compositions containing them, starting materials and their preparation
PT87699A (pt) Process for the preparation of tricyclic pyridone derivatives and of pharmaceutical compositions containing the same
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
IL61675A0 (en) N-substituted -amino acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
PT75868A (fr) Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant
PT83984A (en) Process for the preparation of novel 16,17-acetalsubstituted pregnane 21-oic derivatives and of pharmaceutical compositions containing the same
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
DE2861570D1 (en) 17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them
GB2015525B (en) Naphthopytan derivatives the salts thereof processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980731